Evidence map›Paper›PMID 38785841›Full record

ArticleBiology2024

Correction: Satam et al. Next-Generation Sequencing Technology: Current Trends and Advancements.

Heena Satam, Kandarp Joshi, Upasana Mangrolia, Sanober Waghoo, Gulnaz Zaidi, Shravani Rawool, Ritesh P Thakare, Shahid Banday, Alok K Mishra, Gautam Das and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Insights Into Spatial Transcriptomics: Exploring Recent Technical Developments and Their Diverse Applications.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Heena SatammiBiome Therapeutics, Mumbai 400102, India.
Kandarp JoshimiBiome Therapeutics, Mumbai 400102, India.ORCID 0000-0002-2153-0110
Upasana MangroliamiBiome Therapeutics, Mumbai 400102, India.ORCID 0000-0001-7670-0239
Sanober WaghoomiBiome Therapeutics, Mumbai 400102, India.
Gulnaz ZaidimiBiome Therapeutics, Mumbai 400102, India.ORCID 0009-0007-8149-0388
Shravani RawoolmiBiome Therapeutics, Mumbai 400102, India.
Ritesh P ThakareDepartment of Molecular Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA 01605, USA.ORCID 0000-0002-7426-2519
Shahid BandayDepartment of Molecular Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA 01605, USA.ORCID 0000-0001-8539-6662
Alok K MishraDepartment of Molecular Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA 01605, USA.ORCID 0000-0002-7742-2426
Gautam DasmiBiome Therapeutics, Mumbai 400102, India.
Sunil K MaloniaDepartment of Molecular Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA 01605, USA.ORCID 0000-0002-2727-5165

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We are very thankful to the commentator for pointing out the issues in the review article by Satam et al [...].

Identifiers

PMID38785841
PMCPMC11107263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.